---
title: "Nuclear Pharma Breakthroughs, Snack Profit Surge Define Hong Kong's Niche Stock Momentum"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/302535123.md"
description: "China Isotope (1763.HK) secured dual-dose urea breath test approval and Lu-177 DMF activation with FDA, while TS Wonders reported 51.8% net profit growth. Gome Retail's loss narrowed 76.67%, signaling selective recovery in Hong Kong's small-cap sector."
datetime: "2026-10-21T09:17:45.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/302535123.md)
  - [en](https://longbridge.com/en/news/302535123.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/302535123.md)
generator: "portal-rs"
---

# Nuclear Pharma Breakthroughs, Snack Profit Surge Define Hong Kong's Niche Stock Momentum

In Hong Kong's overlooked small-cap segment, quiet transformations are underway. China Isotope (1763.HK) has cleared two critical hurdles: its 50mg urea breath test kit received NMPA approval for 幽门螺杆菌 diagnosis, while subsidiary CNNC-HT's Lu-177 raw material DMF activation with FDA opens US market pathways. Snack producer TS Wonders (1767.HK) stunned markets with 51.8% net profit growth on 8.9% revenue increase, driven by nut segment expansion.

Retail sector shows contrasting trajectories. Gome Retail (0493.HK) narrowed losses by 76.67% YoY despite 40.74% revenue drop, as strategic shift to asset-light model gains traction. Hang Lung Group (0010.HK) signaled confidence through selective share acquisitions in premium mall portfolio.

Healthcare and consumer plays reveal mixed signals. Dental chain Dazhong Oral (2651.HK) executed 10:2 bonus issue amid significant shareholding restructuring, while apparel OEM Ying Mei (2368.HK) maintained dividend payout despite 20.1% profit decline. Tea retailer Ying Ji Group (8241.HK) appointed new CFO during three-year revenue slump, and Fu Yu Holdings (8269.HK) saw consumer goods trade collapse 22.59% though financial education segment held steady. Hong Kong Ferry (0050.HK) maintained ultra-low volatility with diversified business mix.

These developments, though scattered across sectors, collectively suggest pockets of resilience in Hong Kong's niche stock universe.

### Related Stocks

- [01763.HK](https://longbridge.com/en/quote/01763.HK.md)
- [08269.HK](https://longbridge.com/en/quote/08269.HK.md)
- [08241.HK](https://longbridge.com/en/quote/08241.HK.md)
- [02651.HK](https://longbridge.com/en/quote/02651.HK.md)
- [00493.HK](https://longbridge.com/en/quote/00493.HK.md)
- [01767.HK](https://longbridge.com/en/quote/01767.HK.md)
- [02368.HK](https://longbridge.com/en/quote/02368.HK.md)
- [00050.HK](https://longbridge.com/en/quote/00050.HK.md)
- [00010.HK](https://longbridge.com/en/quote/00010.HK.md)

## Related News & Research

- [Tweedy, Browne initiate multiple new positions and exit several holdings in Q3 2026](https://longbridge.com/en/news/306287552.md)
- [China Isotope & Radiation Appoints Li Penghui as Executive Director](https://longbridge.com/en/news/302575482.md)
- [China Isotope & Radiation Files List of Directors and Board Committee Members](https://longbridge.com/en/news/302576499.md)
- [China Isotope & Radiation Wins Strong Shareholder Backing at 2026 Extraordinary Meeting](https://longbridge.com/en/news/302579967.md)
- [China Isotope & Radiation Subsidiary CNGT Seeks Investors for 20% Stake via Public Tender](https://longbridge.com/en/news/302578542.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**